Cargando…
Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma
INTRODUCTION: The severe acute respiratory syndrome-2 (SARS-CoV-2) pandemic disrupted medical care for persons with cancer including those with lymphoma. Many professional societies recommend postponing, decreasing, or stopping anti-cancer therapy in selected persons during the pandemic. Although se...
Autores principales: | Yang, Shenmiao, Dong, Dong, Gu, Hongfei, Gale, Robert Peter, Ma, Jun, Huang, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571863/ https://www.ncbi.nlm.nih.gov/pubmed/33078214 http://dx.doi.org/10.1007/s00432-020-03426-0 |
Ejemplares similares
-
Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2
por: Dong, Shuang, et al.
Publicado: (2020) -
Safety and Feasibility of Surgery for Oropharyngeal Cancers During the SARS-CoV-2-Pandemic
por: Gorphe, Philippe, et al.
Publicado: (2021) -
Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
por: Tang, Patrick Chun Hean, et al.
Publicado: (2022) -
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
por: Li, Huan, et al.
Publicado: (2020) -
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic
por: Gurizzan, Cristina, et al.
Publicado: (2021)